1	RNA	RNA	B-NP	NN	O	2	NMOD	0
2	damage	damage	I-NP	NN	O	4	NMOD	0
3	and	and	O	CC	O	4	NMOD	0
4	inhibition	inhibition	B-NP	NN	O	11	NMOD	18	inhibition
5	of	of	B-PP	IN	O	4	NMOD	0
6	neoplastic	neoplastic	B-NP	JJ	O	9	NMOD	0
7	endothelial	endothelial	I-NP	JJ	O	9	NMOD	0
8	cell	cell	I-NP	NN	O	9	NMOD	0
9	growth	growth	I-NP	NN	O	5	PMOD	1	growth
10	:	:	O	:	O	4	P	0
11	effects	effect	B-NP	NNS	O	0	ROOT	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	human	human	B-NP	JJ	O	16	NMOD	0
14	and	and	I-NP	CC	O	16	NMOD	0
15	amphibian	amphibian	I-NP	JJ	B-protein	16	NMOD	0
16	ribonucleases	ribonucleas	I-NP	NNS	I-protein	12	PMOD	0
17	.	.	O	.	O	11	P	0

1	Angiogenesis	Angiogenesis	B-NP	NN	O	2	SUB	3	Angiogenesis
2	defines	define	B-VP	VBZ	O	0	ROOT	0
3	the	the	B-NP	DT	O	5	NMOD	0
4	many	many	I-NP	JJ	O	5	NMOD	0
5	steps	step	I-NP	NNS	O	2	OBJ	0
6	involved	involve	B-VP	VBN	O	5	NMOD	0
7	in	in	B-PP	IN	O	6	VMOD	0
8	the	the	B-NP	DT	O	11	NMOD	0
9	growth	growth	I-NP	NN	O	11	NMOD	4	growth
10	and	and	I-NP	CC	O	11	NMOD	0
11	migration	migration	I-NP	NN	O	7	PMOD	14	migration
12	of	of	B-PP	IN	O	11	NMOD	0
13	endothelial	endothelial	B-NP	JJ	B-cell_type	16	NMOD	0
14	cell-derived	cell-derived	I-NP	JJ	I-cell_type	16	NMOD	2	derived
15	blood	blood	I-NP	NN	I-cell_type	16	NMOD	0
16	vessels	vessel	I-NP	NNS	I-cell_type	12	PMOD	0
17	.	.	O	.	O	2	P	0

1	This	This	B-NP	DT	O	2	NMOD	0
2	process	process	I-NP	NN	O	3	SUB	0
3	is	be	B-VP	VBZ	O	16	VMOD	0
4	necessary	necessary	B-ADJP	JJ	O	3	PRD	0
5	for	for	B-PP	IN	O	4	AMOD	0
6	the	the	B-NP	DT	O	9	NMOD	0
7	growth	growth	I-NP	NN	O	9	NMOD	4	growth
8	and	and	I-NP	CC	O	9	NMOD	0
9	metastasis	metastasis	I-NP	NN	O	5	PMOD	14	metastasis
10	of	of	B-PP	IN	O	9	NMOD	0
11	tumors	tumor	B-NP	NNS	O	10	PMOD	0
12	,	,	O	,	O	16	P	0
13	and	and	O	CC	O	16	VMOD	0
14	considerable	considerable	B-NP	JJ	O	15	NMOD	0
15	effort	effort	I-NP	NN	O	16	SUB	0
16	is	be	B-VP	VBZ	O	0	ROOT	0
17	being	be	I-VP	VBG	O	16	VC	0
18	expended	expend	I-VP	VBN	O	17	VC	0
19	to	to	I-VP	TO	O	20	VMOD	0
20	find	find	I-VP	VB	O	18	VMOD	0
21	inhibitors	inhibitor	B-NP	NNS	O	20	OBJ	0
22	of	of	B-PP	IN	O	21	NMOD	0
23	tumor	tumor	B-NP	NN	O	24	NMOD	0
24	angiogenesis	angiogenesis	I-NP	NN	O	22	PMOD	3	angiogenesis
25	.	.	O	.	O	16	P	0

1	This	This	B-NP	DT	O	3	SUB	0
2	usually	usually	B-ADVP	RB	O	3	VMOD	0
3	involves	involve	B-VP	VBZ	O	0	ROOT	0
4	screening	screening	B-NP	NN	O	3	OBJ	0
5	of	of	B-PP	IN	O	4	NMOD	0
6	potential	potential	B-NP	JJ	O	8	NMOD	0
7	anti-angiogenic	anti-angiogenic	I-NP	JJ	O	8	NMOD	3	angiogenic
8	compounds	compound	I-NP	NNS	O	5	PMOD	0
9	on	on	B-PP	IN	O	8	NMOD	0
10	endothelial	endothelial	B-NP	JJ	B-cell_type	11	NMOD	0
11	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	0
12	.	.	O	.	O	3	P	0

1	To	To	B-PP	TO	O	18	SUB	0
2	this	this	B-NP	DT	O	3	NMOD	0
3	end	end	I-NP	NN	O	1	PMOD	0
4	,	,	O	,	O	16	P	0
5	two	two	B-NP	CD	O	9	NMOD	0
6	candidate	candidate	I-NP	NN	O	9	NMOD	0
7	anti-angiogenic	anti-angiogenic	I-NP	JJ	O	9	NMOD	3	angiogenic
8	RNA-damaging	RNA-damaging	I-NP	JJ	O	9	NMOD	0
9	agents	agent	I-NP	NNS	O	16	NMOD	0
10	,	,	O	,	O	16	P	0
11	onconase	onconase	B-NP	NN	O	16	NMOD	0
12	and	and	O	CC	O	16	NMOD	0
13	(	(	O	(	O	14	DEP	0
14	-4	-4	O	CD	O	15	DEP	0
15	)	)	O	)	O	16	NMOD	0
16	rhEDN	rhEDN	B-NP	NN	O	1	VMOD	0
17	,	,	O	,	O	1	P	0
18	were	be	B-VP	VBD	O	0	ROOT	0
19	screened	screen	I-VP	VBN	O	18	VC	0
20	for	for	B-PP	IN	O	19	VMOD	0
21	their	their	B-NP	PRP$	O	22	NMOD	0
22	effects	effect	I-NP	NNS	O	20	PMOD	16	effects
23	on	on	B-PP	IN	O	22	NMOD	0
24	endothelial	endothelial	B-NP	JJ	B-cell_type	26	NMOD	0
25	cell	cell	I-NP	NN	I-cell_type	26	NMOD	0
26	proliferation	proliferation	I-NP	NN	O	23	PMOD	1	proliferation
27	using	use	B-VP	VBG	O	18	VMOD	0
28	three	three	B-NP	CD	O	30	NMOD	0
29	distinct	distinct	I-NP	JJ	O	30	NMOD	0
30	types	type	I-NP	NNS	O	27	OBJ	0
31	of	of	B-PP	IN	O	30	NMOD	0
32	endothelial	endothelial	B-NP	JJ	B-cell_type	33	NMOD	0
33	cells	cell	I-NP	NNS	I-cell_type	31	PMOD	0
34	in	in	B-PP	IN	O	30	NMOD	0
35	culture	culture	B-NP	NN	B-cell_line	34	PMOD	0
36	:	:	O	:	I-cell_line	43	P	0
37	HPV-16	HPV-16	B-NP	NN	I-cell_line	43	NMOD	0
38	E6/E7-immortalized	E6/E7-immortalized	I-NP	JJ	I-cell_line	43	NMOD	19	immortalized
39	human	human	I-NP	JJ	I-cell_line	43	NMOD	0
40	umbilical	umbilical	I-NP	JJ	I-cell_line	43	NMOD	0
41	vein	vein	I-NP	NN	I-cell_line	43	NMOD	0
42	endothelial	endothelial	I-NP	JJ	I-cell_line	43	NMOD	0
43	cells	cell	I-NP	NNS	I-cell_line	52	NMOD	0
44	(	(	O	(	O	46	DEP	0
45	HUVECs	HUVEC	B-NP	NNS	B-cell_line	46	DEP	0
46	)	)	O	)	O	43	NMOD	0
47	,	,	O	,	O	52	P	0
48	a	a	B-NP	DT	O	52	NMOD	0
49	Kras-transformed	Kras-transformed	I-NP	JJ	B-cell_line	52	NMOD	19	transformed
50	HPV-16	HPV-16	I-NP	NN	I-cell_line	52	NMOD	0
51	E6/E7	E6/E7	I-NP	NN	I-cell_line	52	NMOD	0
52	HUVEC	HUVEC	I-NP	NN	I-cell_line	68	NMOD	0
53	(	(	O	(	O	64	DEP	0
54	Rhim	Rhim	B-NP	NNP	O	63	NMOD	0
55	et	et	I-NP	FW	O	54	NMOD	0
56	al.	al.	I-NP	FW	O	54	NMOD	0
57	,	,	O	,	O	63	P	0
58	Carcinogenesis	Carcinogenesis	B-NP	NNP	O	63	NMOD	0
59	4	4	I-NP	CD	O	58	NMOD	0
60	,	,	I-NP	,	O	63	P	0
61	673-681	673-681	I-NP	CD	O	63	NMOD	0
62	,	,	I-NP	,	O	63	P	0
63	1998	1998	I-NP	CD	O	64	DEP	0
64	)	)	O	)	O	52	NMOD	0
65	,	,	O	,	O	68	P	0
66	and	and	O	CC	O	68	NMOD	0
67	primary	primary	B-NP	JJ	B-cell_type	68	NMOD	0
68	HUVECs	HUVEC	I-NP	NNS	I-cell_type	27	VMOD	0
69	.	.	O	.	O	18	P	0

1	Onconase	Onconase	B-NP	NN	B-protein	3	SUB	0
2	similarly	similarly	B-ADVP	RB	O	3	VMOD	0
3	inhibited	inhibit	B-VP	VBD	O	0	ROOT	18	inhibited
4	proliferation	proliferation	B-NP	NN	O	3	OBJ	1	proliferation
5	in	in	B-PP	IN	O	3	VMOD	0
6	all	all	B-NP	DT	O	9	NMOD	0
7	three	three	I-NP	CD	O	9	NMOD	0
8	cell	cell	I-NP	NN	B-cell_line	9	NMOD	0
9	lines	line	I-NP	NNS	I-cell_line	5	PMOD	0
10	(	(	O	(	O	18	DEP	0
11	IC	IC	B-NP	NN	O	18	DEP	0
12	(	(	O	(	O	14	DEP	0
13	50	50	B-NP	CD	O	14	DEP	0
14	)	)	O	)	O	11	NMOD	0
15	=	=	B-VP	SYM	O	11	NMOD	0
16	0.3-1.0	0.3-1.0	B-NP	CD	O	17	NMOD	0
17	microM	microM	I-NP	NN	O	15	AMOD	0
18	)	)	O	)	O	9	NMOD	0
19	while	while	B-SBAR	IN	O	3	VMOD	0
20	(	(	O	(	O	22	DEP	0
21	-4	-4	B-NP	CD	O	22	DEP	0
22	)	)	O	)	O	23	NMOD	0
23	rhEDN	rhEDN	B-NP	NN	O	24	SUB	0
24	was	be	B-VP	VBD	O	19	SBAR	0
25	more	more	B-ADJP	RBR	O	26	AMOD	0
26	effective	effective	I-ADJP	JJ	O	24	PRD	17	effective
27	on	on	B-PP	IN	O	26	AMOD	0
28	immortalized	immortalize	B-NP	VBN	O	31	NMOD	19	immortalized
29	HUVEC	HUVEC	I-NP	NN	B-cell_line	31	NMOD	0
30	cell	cell	I-NP	NN	I-cell_line	31	NMOD	0
31	lines	line	I-NP	NNS	I-cell_line	27	PMOD	0
32	(	(	O	(	O	40	DEP	0
33	IC	IC	B-NP	NN	O	40	DEP	0
34	(	(	O	(	O	36	DEP	0
35	50	50	B-NP	CD	O	36	DEP	0
36	)	)	O	)	O	33	NMOD	0
37	=	=	B-VP	SYM	O	33	NMOD	0
38	0.02-0.06	0.02-0.06	B-NP	CD	O	39	NMOD	0
39	microM	microM	I-NP	NN	O	37	AMOD	0
40	)	)	O	)	O	31	NMOD	0
41	than	than	B-PP	IN	O	26	AMOD	0
42	on	on	B-PP	IN	O	41	PMOD	0
43	primary	primary	B-NP	JJ	B-cell_type	44	NMOD	0
44	HUVECs	HUVEC	I-NP	NNS	I-cell_type	42	PMOD	0
45	(	(	O	(	O	53	DEP	0
46	IC	IC	B-NP	NN	O	52	NMOD	0
47	(	(	O	(	O	49	DEP	0
48	50	50	B-NP	CD	O	49	DEP	0
49	)	)	O	)	O	52	NMOD	0
50	>	>	B-NP	JJR	O	52	NMOD	0
51	0.1	0.1	I-NP	CD	O	52	NMOD	0
52	microM	microM	I-NP	NN	O	53	DEP	0
53	)	)	O	)	O	44	NMOD	0
54	.	.	O	.	O	3	P	0

1	Differential	Differential	B-NP	JJ	O	2	NMOD	0
2	sensitivity	sensitivity	I-NP	NN	O	6	SUB	0
3	to	to	B-PP	TO	O	2	NMOD	0
4	these	these	B-NP	DT	O	5	NMOD	0
5	agents	agent	I-NP	NNS	O	3	PMOD	0
6	implies	imply	B-VP	VBZ	O	0	ROOT	0
7	that	that	B-SBAR	IN	O	6	VMOD	0
8	more	more	B-NP	JJR	O	9	AMOD	0
9	than	than	I-NP	IN	O	13	NMOD	0
10	one	one	I-NP	CD	O	9	AMOD	0
11	endothelial	endothelial	I-NP	JJ	O	13	NMOD	0
12	cell	cell	I-NP	NN	O	13	NMOD	0
13	type	type	I-NP	NN	O	14	SUB	0
14	must	must	B-VP	MD	O	7	SBAR	0
15	be	be	I-VP	VB	O	14	VC	0
16	used	use	I-VP	VBN	O	15	VC	0
17	in	in	B-PP	IN	O	16	VMOD	0
18	proliferation	proliferation	B-NP	NN	O	19	NMOD	1	proliferation
19	assays	assay	I-NP	NNS	O	17	PMOD	0
20	to	to	B-VP	TO	O	21	VMOD	0
21	screen	screen	I-VP	VB	O	14	VMOD	0
22	for	for	B-PP	IN	O	21	VMOD	0
23	novel	novel	B-NP	JJ	O	25	NMOD	0
24	anti-angiogenic	anti-angiogenic	I-NP	JJ	O	25	NMOD	3	angiogenic
25	compounds	compound	I-NP	NNS	O	22	PMOD	0
26	.	.	O	.	O	6	P	0

